Vivolta specializes in the development and manufacturing of electrospun medical products that facilitate the body's natural healing processes. Their core technology, medical electrospinning, allows for the creation of nano- and microfiber-based materials that closely mimic the structure of the human extracellular matrix. This biomimetic architecture enhances tissue integration and reduces complications associated with traditional medical materials, such as scar tissue formation. Vivolta's electrospun biomaterials are designed to be biocompatible and can be tailored to be either resorbable or biostable, making them suitable for a wide range of medical applications, including cardiovascular implants, soft tissue reconstruction, and advanced wound healing.

The company employs a comprehensive approach to product development, integrating quality-by-design principles throughout the process. From initial concept design to commercial manufacturing, Vivolta ensures that only medical-grade polymers are used, adhering to ISO13485 standards. Their proprietary MediSpin™ platform enables scalable production with automated quality control systems, ensuring traceability and consistency in the manufacturing of clinical-grade products. This innovative approach not only accelerates the development timeline but also enhances the performance and safety of the electrospun medical products, ultimately improving patient outcomes.

Netherlands

VIVOLTA is the healthcare industry's trusted partner for contract development and manufacturing of electrospun medical products that guide the body to heal itself. Founded in 2008, we leverage our proud heritage as high-performance electrospinning equipment designer now as a leading CDMO for electrospun medical devices and drug delivery systems.

Vivolta

Company Details